106840-37-3

Basic information

• Product Name: Ethyl 2-(acetylamino)-1,3-thiazole-5-carboxylate, 2-Acetamido-5-(ethoxycarbonyl)-1,3-thiazole
• Synonyms: Ethyl 2-(acetylamino)-1,3-thiazole-5-carboxylate, 2-Acetamido-5-(ethoxycarbonyl)-1,3-thiazole;Ethyl 2-acetamido-1,3-thiazole-5-carboxylate;2-acetaMidothiazol-5-carboxylic acid ethyl ester;2-AcetylaMinothiazole-5-carboxylic acid ethyl ester;ethyl 2-acetamidothiazole-5-carboxylate
• CAS NO: 106840-37-3
• Molecular Formula: C8H10N2O3S
• Molecular Weight: 214.2416
• Mol File: 106840-37-3.mol

Chemical Properties

• Appearance: /
• Density: 1.342g/cm³
• Refractive Index: 1.584
• CAS DataBase Reference: Ethyl 2-(acetylamino)-1,3-thiazole-5-carboxylate, 2-Acetamido-5-(ethoxycarbonyl)-1,3-thiazole(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 2-(acetylamino)-1,3-thiazole-5-carboxylate, 2-Acetamido-5-(ethoxycarbonyl)-1,3-thiazole(106840-37-3)
• EPA Substance Registry System: Ethyl 2-(acetylamino)-1,3-thiazole-5-carboxylate, 2-Acetamido-5-(ethoxycarbonyl)-1,3-thiazole(106840-37-3)

Safety Data

• Hazardous Substances Data: 106840-37-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 2-(acetylamino)-1,3-thiazole-5-carboxylate and 2-Acetamido-5-(ethoxycarbonyl)-1,3-thiazole are used as intermediates in the synthesis of pharmaceutical compounds for their potential medicinal properties.
Used in Organic Chemistry:
Ethyl 2-(acetylamino)-1,3-thiazole-5-carboxylate and 2-Acetamido-5-(ethoxycarbonyl)-1,3-thiazole are used as reagents in organic chemistry reactions due to their ester-like properties and the presence of the thiazole ring.

InChI:InChI=1/C8H10N2O3S/c1-3-13-7(12)6-4-9-8(14-6)10-5(2)11/h4H,3H2,1-2H3,(H,9,10,11)

Upstream product

• 33142-21-1 ethyl 2-chloro-3-oxopropanoate 
• 591-08-2 acetylthiourea 
• 32955-21-8 2-amino-thiazole-5-carboxylic acid ethyl ester 
• 75-36-5 acetyl chloride 
• 108-24-7 acetic anhydride 

Relevant articles and documents

SPIRO COMPOUNDS AS GLYCOSIDASE INHIBITORS

Compounds of formula (I) wherein A, R, L, Z, Q1, Q2 and n have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

PYRROLIDINE GLYCOSIDASE INHIBITORS

Compounds of formula (I) wherein A, W, R3b, Z and p have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

FUSED GLYCOSIDASE INHIBITORS

Compounds of formula (I), wherein A, Z, E, R1, R2, m and n have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLYCOPYRANOSIDASE INHIBITORS

Described herein are compounds represented by formula (I") or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of preparing and using the same. The variables Ar, Ra, Rb, m, n, Y

GLYCOSIDASE INHIBITORS

Compounds of formula (I) wherein X1, X2, W, R1 to R5, L and m have the meaning according to the claims, are glucosidase inhibitors, and can be employed, inter alia, for the treatment of Alzheimer's disease.